Article
New insights from the widening homogeneity perspective to target intratumor heterogeneity.
Cancer communications (London, England) - 4 May 2018
Tong Mengying, Deng Ziqian, Zhang Xiaolong, He Bin, Yang Mengying, Cheng Wei, Liu Quentin
Abstract excerpt
Precision medicine has shed new light on the treatment of heterogeneous cancer patients. However, intratumor heterogeneity strongly constrains the clinical benefit of precision medicine. Thus, rethinking therapeutic strategies from a different facet within the precision medicine framework will not only diversify clinical interventions, but also provide an avenue for precision medicine. Here, we explore the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
